Tori Rodriguez, MA, LPC, AHC

Contributing Writer

Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years. She holds a BS in psychology from Georgia State University and an MA in counseling psychology from the Georgia School of Professional Psychology. Tori has also managed a medical practice and was instrumental in developing Georgia’s multispecialty telemedicine program. Photograph courtesy of Brooklyn Brat Images.

All articles by Tori Rodriguez, MA, LPC, AHC

WCLC 2022

COVID-19 Should Not Delay Cancer Treatment in Patients With Thoracic Cancer, Data Suggest

Tori Rodriguez, MA, LPC, AHC

August 22, 2022

Recent exposure to systemic treatment does not increase the risk of 30-day mortality in patients with thoracic cancers and COVID-19.

WCLC 2022

Long-Term Exposure to Air Pollution and Risk of Lung Cancer

Tori Rodriguez, MA, LPC, AHC

August 18, 2022

Long-term cumulative exposure to air pollution should be included in assessments of lung cancer risk, according to researchers.

WCLC 2022

Consent Forms for Clinical Trials Prove Too Long and Complex for Patients

Tori Rodriguez, MA, LPC, AHC

August 17, 2022

Consent forms could be improved by a patient-centric addendum highlighting key points, a study suggests.

WCLC 2022

First-Line Pembrolizumab Improves Outcomes in Extensive-Stage Small Cell Lung Cancer

Tori Rodriguez, MA, LPC, AHC

August 16, 2022

Adding pembrolizumab to chemotherapy can improve survival in extensive-stage small cell lung cancer, a phase 3 study suggests.

WCLC 2022

Sexual Dysfunction Common but Unique in Women With Lung Cancer

Tori Rodriguez, MA, LPC, AHC

August 15, 2022

Researchers found that 77% of patients had moderate to severe sexual dysfunction.

WCLC 2022

Vaccination May Prevent Severe COVID-19 in Patients With Lung Cancer

Tori Rodriguez, MA, LPC, AHC

August 12, 2022

COVID-19 vaccination does not appear to prevent SARS-CoV-2 infection in patients with lung cancer, but it may prevent severe COVID-19.

WCLC 2022

Sugemalimab Consolidation Could Be New Standard in Stage III NSCLC

Tori Rodriguez, MA, LPC, AHC

August 11, 2022

Sugemalimab consolidation improved progression-free survival, when compared with placebo, in patients with unresectable, stage III non-small cell lung cancer.

WCLC 2022

Neoadjuvant Nivolumab Improves PFS, OS in Stage IIIA-B Non-Small Cell Lung Cancer

Tori Rodriguez, MA, LPC, AHC

August 11, 2022

Adding nivolumab to neoadjuvant platinum-based chemotherapy can improve survival in patients with stage IIIA-B non-small cell lung cancer, new data suggest.